NeoGenomics Now Covered by Analysts at William Blair (NGNM)
Investment analysts at William Blair assumed coverage on shares of NeoGenomics (OTC:NGNM) in a note issued to investors on Wednesday, AR Network reports. The firm set an “outperform” rating on the stock.
NeoGenomics, Inc (OTC:NGNM) operates a network of cancer-focused testing laboratories.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.